Paperpal Prime Logo

Innate Immunity : Impact Factor & More

eISSN: 1753-4267pISSN: 1753-4259
JournalOpen Access

Aims and Scope of Innate Immunity

Innate Immunity is a peer-reviewed scientific journal covering innate immunity in humans, animals, and plants. It is published by SAGE Publications on behalf of the International Endotoxin & Innate Immunity Society and the editor-in-chief is Otto Holst (Research Centre Borstel, Germany). The journal was established in 1994 as the Journal of Endotoxin Research and obtained its current title in 2006. Less

Key Metrics

CiteScore
4.8
H-Index
75
Impact Factor
< 5
SJR
Q2Immunology
SNIP
0.74
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Innate Immunity

Innate Immunity Journal Specifications

Overview
Publisher SAGE PUBLICATIONS LTD
Language English
Frequency Bi-monthly
Article Processing ChargesUSD 2000
Publication Time11
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
Society/Institute/SponsorInternational Endotoxin & Innate Immunity Society (IEIIS)
FrequencyBi-monthly
Publication Start Year2008
Publisher URLVisit website
Website URLVisit website
Publication Details
Other chargesVisit website
PlagiarismVisit website
Publication Time 11
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY, CC BY-NC
OA statementVisit website
View less

Planning to publish in Innate Immunity ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Innate Immunity

Diagnostic value of cerebrospinal fluid antisuprabasin antibody in neuropsychiatric systemic lupus erythematosus
  • 6 Aug 2026
  • Lupus Science & Medicine
Occurrence of venous thromboembolism in SLE: findings from a nationwide cohort and a clinical cohort in Sweden
  • 6 Aug 2026
  • Lupus Science & Medicine
High disease activity persists in adults with childhood-onset lupus
  • 5 Aug 2026
  • Lupus Science & Medicine
Peripheral blood CD19+B cell proportion at baseline predicts early complete response to belimumab treatment in patients with refractory lupus nephritis
  • 3 Aug 2026
  • Lupus Science & Medicine
Role of repeat kidney biopsy after 6 months of treatment in proliferative lupus nephritis
  • 31 Jul 2026
  • Lupus Science & Medicine
Lupus Nexus: developing a prospective registry, biorepository and data exchange platform to foster global collaborations, accelerate research innovation and advance precision medicine in lupus
  • 28 Jul 2026
  • Lupus Science & Medicine
Diagnostic value of cerebrospinal fluid antisuprabasin antibody in neuropsychiatric systemic lupus erythematosus
  • 6 Aug 2026
  • Lupus Science & Medicine
Occurrence of venous thromboembolism in SLE: findings from a nationwide cohort and a clinical cohort in Sweden
  • 6 Aug 2026
  • Lupus Science & Medicine
High disease activity persists in adults with childhood-onset lupus
  • 5 Aug 2026
  • Lupus Science & Medicine
Peripheral blood CD19+B cell proportion at baseline predicts early complete response to belimumab treatment in patients with refractory lupus nephritis
  • 3 Aug 2026
  • Lupus Science & Medicine
Role of repeat kidney biopsy after 6 months of treatment in proliferative lupus nephritis
  • 31 Jul 2026
  • Lupus Science & Medicine
Lupus Nexus: developing a prospective registry, biorepository and data exchange platform to foster global collaborations, accelerate research innovation and advance precision medicine in lupus
  • 28 Jul 2026
  • Lupus Science & Medicine

FAQs on Innate Immunity